Cancer
Drug dramatically shrinks Prostate Tumors, study finds - July 23, 2008
There is a general sense in the prostate cancer community that this agent is
extremely promising and is very likely to have an important role in the
management of prostate cancer patients,' said Dr. Howard M. Sandler, a
radiation oncologist at the University of Michigan who is a spokesman for the
American Society of Clinical Oncology.'It's pretty safe to say that we are
going to have a lot more to offer patients when this drug gets approved,' added
Dr. Robert Reiter, a urologist at UCLA's Jonsson Comprehensive Cancer Center
who was not involved in the research.
Radiation
helps even when Prostate Cancer returns - June 17, 2008
Radiation therapy can help prolong the lives of men with aggressive prostate
cancer whose tumors return after surgery, U.S. researchers said on Tuesday.
Radiation therapy given within two years of recurrence cut the risk of dying
from prostate cancer by two-thirds, compared with those who got no additional
treatment, they said.
A new prostate cancer vaccine may give hope to men with metastatic prostate
cancer by enabling their immune systems to fight the disease. Researchers from
the
University
of
Iowa
presented data on the adenovirus/PSA (Ad/PSA) vaccine during the Annual
Scientific Meeting of the American Urological Association in
Orlando
.
In recent years, the concept of vaccine immunotherapy for advanced prostate
cancer has become increasingly high profile as research has expanded. Major
advances in the field have contributed significantly to the discussion of this
important cancer therapy as researchers explore new ways to prolong survival
and improve the quality of life in patients with metastatic disease.
Prostate-screening exams may miss cancer in obese patients, study shows
- November 27, 2007
Higher blood volumes probably cause lower concentrations of prostate-specific
antigen, or PSA, in obese prostate cancer patients, reports a study, leading
the authors to speculate screening with PSA tests might miss some cancers in
obese men.
Study Supports Change to Prostate Cancer Biopsy -
October 2, 2007
Adding an extra step to the standard test for prostate cancer might improve
treatment for some men, a new study finds.
Glaxo's Avodart and Flomax Help Prostate, Study Says (Update1)
- September 4, 2007
GlaxoSmithKline Plc's Avodart combined with Boehringer Ingelheim GmbH's Flomax
improved symptoms of enlarged prostate gland better than either drug alone, a
study found.
HIS HEALTH - Diet and prostate cancer - August 15, 2007
One's diet is believed to play an important role in the causation of
prostate cancer.
Epidemiological studies, looking at different populations where the incidence
of prostate cancer varies widely, suggest that differences in diet may partly
account for these variations.
Soy isoflavones may halve prostate cancer risk -
July 25, 2007
Increased intake of soy isoflavones may cut the risk of prostate cancer by 58
per cent, suggests a new study from
Japan
.
Can Changing Your Lifestyle Help Treat Prostate Cancer? - July 9,
2007
Up to 73% of men with prostate cancer take nonprescription supplements, and
smaller numbers use diet, exercise, or both in the hope of improving their
outcome. Most of these men also receive conventional therapy, but a few depend
on lifestyle alone. The appeal of lifestyle therapy is obvious but does it
work?